News

Fungal Meningitis Outbreak Exposes Lack of Regulatory Oversight


 

The 23 states that received the implicated lots of medication are California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, and West Virginia.

All reports of complaints or problems associated with these products should be made at the MedWatch website, the FDA’s voluntary reporting program, or by calling 800-FDA-1088.

Pages

Recommended Reading

Chronic Musculoskeletal Pain Travels with Chronic Daily Headache
MDedge Family Medicine
Yoga, Tai Chi Underused in Rheumatic Pain Management
MDedge Family Medicine
Botox for Chronic Migraine Brings Cost Savings
MDedge Family Medicine
Botox May Greatly Reduce Migraine Chronicity
MDedge Family Medicine
Fungal Meningitis Cases, Deaths Continue to Rise
MDedge Family Medicine
Weighing Botox's Migraine Benefits Against Costs
MDedge Family Medicine
Sickle cell disease: Gaining control over the pain
MDedge Family Medicine
What treatments relieve painful heel cracks?
MDedge Family Medicine
Antibiotics fail to head off sepsis … Failure to address persistent symptoms proves disastrous… more
MDedge Family Medicine
Painful growths
MDedge Family Medicine